Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>PHARMARON (03759.HK) Full-Year Net Profit RMB1.664 Billion, Down 7.2%; Final Dividend 20 Cents
Recommend 5 Positive 2 Negative 3 |
||||
|
||||
|
PHARMARON (03759.HK) announced its results for the fiscal year 2025, reporting a revenue of RMB14.095 billion, up 14.8% year-on-year. The gross profit was RMB4.857 billion, an increase of 17.1%. The company recorded a net profit of RMB1.664 billion, a decline of 7.2%, with earnings per share of 94.43 cents. The final dividend remains at 20 cents. (de/d) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
